Treatment of resistant human colon cancer xenografts by a fluoxetine–doxorubicin combination enhances therapeutic responses comparable to an aggressive bevacizumab regimen
| Autor: | Argov, Mirit, Kashi, Rina, Peer, Dan, Margalit, Rimona |
|---|---|
| Zdroj: | In Cancer Letters 2009 274(1):118-125 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect